Studying SLD epidemiology in MENA region
Raising the awareness of SLD in the MENA region...
Develop & support SLD research in member countries
Encourage free exchange of SLD data between countries
Steatotic Liver Diseases (SLD)
Steatotic liver disease (SLD) is the overarching term that encompass the various aetiologies of liver steatosis, replacing the old term fatty liver disease. SLD nomenclature and diagnostic criteria are widely supported by the major liver societies, non-stigmatising and can improve awareness and patient identification.
About SLMENA
The overarching goal of the Steatotic Liver Diseases Study Foundation in Middle East and North Africa (SLMENA) is to harness resources and expertise across the Middle East and North Africa (MENA region) to study different aspects and current local challenges in steatotic liver diseases (SLD).
Our Mission
- Develop and support collaborations between member groups
- Raise the awareness of SLD among the doctors of the concerned specialties.
- Identify factors that influence the epidemiology, etiology, pathobiology, prognosis, and treatment of SLD in the MENA region.
- Encourage free exchange of results (published or unpublished) and ideas in a collegial environment for the sake of advancing SLD management in MENA region.
Projects of interest
- Epidemiological studies describing the real situation of SLD in various MENA region countries
- Studying risk factors and disease modifiers in SLD in the MENA region
- SLD Clinical clinical and natural history.
- Studying the role of different serological and radiological non-invasive markers in diagnosing and risk stratifying the disease
- Environmental, patient reported outcomes, and lifestyle factors influencing SLD
- Genetic studies in SLD
- Shape and tailor clinical guidelines and models of care for the diagnosis, clinical management, and treatment of SLD in the MENA region.
Join us
Our Partners
